Spatial Logic Reconciles Gene-signature Methods in Triple Negative Breast Cancer
Triple-Negative Breast Cancer (TNBC) presents a significant clinical challenge due to its heterogeneity and lack of targeted treatment options, with chemotherapy and immunotherapy combinations currently serving as the main therapeutic strategy. Efforts to address TNBC heterogeneity have largely focused on classifying intrinsic cancer subtypes based on differential tumor mRNA expression, a…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
